HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China · Delayed Price · Currency is CNY 3.430
+0.070 (2.08%)
Feb 3, 2026, 3:04 PM CST
SHE:002437 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 293.04 | 232.76 | 120.33 | -291.33 | 45.04 | 400.05 |
Depreciation & Amortization | - | - | - | 130.05 | 144.5 | 149.16 |
Other Amortization | - | - | - | 5.66 | 5.66 | 12.02 |
Loss (Gain) From Sale of Assets | - | - | - | -3.82 | -4.65 | 0.62 |
Asset Writedown & Restructuring Costs | - | - | - | 79.45 | 1.84 | 62.82 |
Loss (Gain) From Sale of Investments | - | - | - | 269.57 | 9.31 | -809.81 |
Provision & Write-off of Bad Debts | - | - | - | -0.31 | -0.53 | 7.33 |
Other Operating Activities | 125.66 | 178.18 | 153.84 | 97.17 | 96.45 | 153.83 |
Change in Accounts Receivable | - | - | - | 55.14 | 133.55 | -9.51 |
Change in Inventory | - | - | - | 120.41 | 22.09 | 27.18 |
Change in Accounts Payable | - | - | - | -191.09 | -183.67 | -138.27 |
Change in Other Net Operating Assets | - | - | - | - | - | 36.92 |
Operating Cash Flow | 418.7 | 410.94 | 274.18 | 261.62 | 274.18 | 12.76 |
Operating Cash Flow Growth | 56.50% | 49.88% | 4.80% | -4.58% | 2048.11% | -97.91% |
Capital Expenditures | -46.72 | -62.9 | -29.62 | -33.01 | -34.51 | -43.66 |
Sale of Property, Plant & Equipment | 12.09 | 18.73 | 13.65 | 40.05 | 3.04 | 5.87 |
Cash Acquisitions | -0.41 | -2.66 | - | - | - | - |
Divestitures | - | - | 0.73 | 2.88 | 74.92 | 1,025 |
Investment in Securities | -385 | -24 | 103.01 | -250 | 31.66 | 11.04 |
Other Investing Activities | 37.21 | 11.97 | 6.61 | 16.2 | 6.15 | 8.39 |
Investing Cash Flow | -382.84 | -58.86 | 94.38 | -223.88 | 81.26 | 1,007 |
Short-Term Debt Issued | - | 115 | 1,095 | 1,556 | 1,948 | 1,677 |
Total Debt Issued | 70 | 115 | 1,095 | 1,556 | 1,948 | 1,677 |
Short-Term Debt Repaid | - | -789.86 | -1,873 | - | -1,672 | -2,982 |
Long-Term Debt Repaid | - | - | - | -1,659 | - | - |
Total Debt Repaid | -44.5 | -789.86 | -1,873 | -1,659 | -1,672 | -2,982 |
Net Debt Issued (Repaid) | 25.5 | -674.86 | -778.13 | -103.02 | 275.42 | -1,305 |
Issuance of Common Stock | - | 103.21 | - | - | - | - |
Common Dividends Paid | -1.02 | -9.36 | -43.81 | -68.76 | -70.94 | -134.48 |
Other Financing Activities | -90.54 | -2.24 | -67.22 | -40.77 | 157.11 | -216.26 |
Financing Cash Flow | -66.06 | -583.24 | -889.16 | -212.55 | 361.59 | -1,656 |
Foreign Exchange Rate Adjustments | 0.65 | 0.94 | 0.99 | 11.92 | -1.57 | -2.86 |
Net Cash Flow | -29.55 | -230.23 | -519.62 | -162.89 | 715.46 | -639.34 |
Free Cash Flow | 371.98 | 348.04 | 244.55 | 228.6 | 239.67 | -30.9 |
Free Cash Flow Growth | 67.10% | 42.32% | 6.98% | -4.62% | - | - |
Free Cash Flow Margin | 16.55% | 14.26% | 9.31% | 7.36% | 7.62% | -1.01% |
Free Cash Flow Per Share | 0.16 | 0.15 | 0.11 | 0.10 | 0.11 | -0.01 |
Cash Income Tax Paid | 232.09 | 255.47 | 265.66 | 287.58 | 280.55 | 311.34 |
Levered Free Cash Flow | 103.38 | 259.53 | -9.97 | 51.24 | 260.36 | 112.82 |
Unlevered Free Cash Flow | 105.18 | 265.67 | 16.69 | 94.16 | 305.04 | 168.16 |
Change in Working Capital | - | - | - | -24.8 | -23.44 | 36.76 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.